Form 8-K - Current report:
SEC Accession No. 0001641172-25-006122
Filing Date
2025-04-25
Accepted
2025-04-25 09:00:45
Documents
18
Period of Report
2025-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49247
2 ex10-1.htm EX-10.1 90682
3 ex10-2.htm EX-10.2 57992
4 ex10-3.htm EX-10.3 20178
5 ex99-1.htm EX-99.1 28080
6 ex99-1_001.jpg GRAPHIC 6210
  Complete submission text file 0001641172-25-006122.txt   488224

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mgrx-20250424.xsd EX-101.SCH 3032
8 XBRL LABEL FILE mgrx-20250424_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE mgrx-20250424_pre.xml EX-101.PRE 22370
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3800
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 25870183
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)